Diagnostic Imaging Market Analysis

Product (X-Ray, MRI, Ultrasound, CT Scanners, Nuclear)

The CT scanners segment is estimated to account for 39% share of the global diagnostic imaging market in the year 2037. The growth of the segment can be attributed to the new product launches in the field. For instance, in January 2020, Allergen, in collaboration with Canon Medical Systems Corporation, introduced a new CT scanner in the market, the ACUTOM 32, which is a 32-slice CT scanner featuring a wide bore gantry of 32 cm, about a 2.0 MHU X-ray tube, and about 0.75 seconds of rotation time. In January of 2022, the Port Perry Hospital Foundation, PPHF succeeded in reaching its USD 4 million goal to purchase a CT scanner and other critical items for Scugog Health Center. Moreover, the prevalence of COVID-19 and the pandemic has increased the demand for diagnostic imaging which contributed to the growth. Due to the rapid increase in COVID-19 cases, Samsung NeuroLogica added a 32-slice mobile BodyTom CT scanner in February 2020.

Application (Cardiology, Urology, Orthopedic, Neurology, Oncology, Gynecology)

Diagnostic imaging market from the oncology segment is expected to garner a significant share during the time period between 2024-2037. The demand for oncology imaging is driven by an increase in the number of cancer cases around the world, together with a growing emphasis on finding and detecting cancers before they develop. This segment of the oncology application is expected to be driven by increasing access to healthcare facilities and diagnostic imaging centers in emerging economies along with a relatively higher compound annual growth rate.

Our in-depth analysis of the global market includes the following segments: